WOLHUSEN, Switzerland: Last week, Geistlich Pharma announced that Diego Gabathuler is the company’s new CEO. An experienced leader and expert in the medical technology industry, the 49-year-old Swiss will guide Geistlich’s expansion strategy in the field of regenerative medicine. Earlier this year, Gabathuler resigned as CEO of Ivoclar after nearly four years in that position. Gabathuler succeeds Dr Ralf Halbach, who left the company in August after almost two years in order to seek new professional challenges.
Dr Andreas Geistlich, who is chairman of the board of directors and served as interim CEO over the past few months, wished the incoming CEO a successful start, saying: “The Geistlich strategic plan includes further investment in new products, solutions and technologies in order to apply regenerative medicine in helping even more people around the world. We are convinced that Diego Gabathuler’s expertise will support us significantly in this mission.”
Geistlich specialises in the regeneration of bone, cartilage and tissue. The company has more than 800 employees worldwide as well as 13 affiliates and 60 distribution partners, through which Geistlich’s medical devices and medicinal products reach around 90 markets worldwide.
In 2019, Gabathuler took over as CEO of Ivoclar from Robert Ganley, who had been Ivoclar’s CEO for 16 years. Under Gabathuler’s leadership, the company achieved excellent operating results in the 2019 and 2021 fiscal years and the highest revenue in its history in 2022. He left Ivoclar in March this year in order to pursue career options outside of the dental industry. Earlier in his career, he held management positions at international digital technology companies such as Logitech, Activision and Electronic Arts.
Tags:
HANAU, Germany: Kulzer, an international provider of dental products and services, has announced the appointment of a new CEO. Marc Berendes succeeds Akira ...
CHARLOTTE, N.C., US: Dentsply Sirona has announced that it has appointed Simon Campion as president and CEO. He will join the company’s board of directors...
COPENHAGEN, Denmark: 3Shape has announced that its board of directors has appointed Jakob Just-Bomholt as CEO, effective from 1 August 2020. The company’s...
SCHAAN, Liechtenstein: Ivoclar has announced that Markus Heinz will replace Diego Gabathuler as CEO of the company. Gabathuler headed the company ...
BREA, Calif., US: Envista Holdings, the company behind leading dental brands such as Nobel Biocare, Ormco, DEXIS and Kerr, has begun the process of finding ...
BREA, Calif., US: Envista Holdings has appointed Paul Keel as its new CEO and a member of its board of directors, effective from 1 May. The company owns ...
WALTHAM, Mass., US: Neoss Group has recently announced the appointment of John Chopack as managing director of Neoss USA. Chopack joined Neoss Group in ...
NEW YORK, US: Global dental supplier Henry Schein has announced three new appointments to the company’s executive management committee. The appointees are...
LUCERNE, Switzerland: Dr Kristian Tersar has been appointed Executive Director of the Osteology Foundation. Tersar, who has already served ad interim in ...
HONG KONG/HARROGATE, UK: CareCapital, an equity investor focused on the dental and oral care industry, has announced an agreement to acquire global dental ...
Live webinar
Thu. 18 July 2024
8:00 pm EST (New York)
Live webinar
Tue. 6 August 2024
6:00 pm EST (New York)
Live webinar
Tue. 13 August 2024
7:00 pm EST (New York)
Live webinar
Wed. 14 August 2024
12:30 pm EST (New York)
Live webinar
Wed. 21 August 2024
9:00 am EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 pm EST (New York)
Live webinar
Mon. 2 September 2024
5:00 am EST (New York)
To post a reply please login or register